Long-term weight reduction of obese patients using femoxetine

Details Long-term weight reduction of obese patients using femoxetine Long-term weight reduction of obese patients using femoxetine

1981-05-07

1984-04-10

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Parasitic organism or component thereof or substance...

A61K 31445

Patent

active

044421133

ABSTRACT:
A method for assisting with appetite and weight control and reduction in obese human patients, which comprises the step of orally or rectally administering an appetite-suppressant compound selected from the group consisting of femoxetine and a pharmaceutically-acceptable salt thereof in an effective appetite-suppressant amount over a period of at least eight (8) weeks is disclosed. The appetite-suppresssant compound is preferably orally administered together with a pharmaceutically-acceptable carrier in a daily dosage of 100 to 1,000 mg in the form of a tablet containing about 100 to 300 mg of the appetite-suppressant compound, which is preferably a pharmaceutically-acceptable femoxetine acid addition salt, especially the hydrochloride.

REFERENCES:
patent: 3912743 (1975-10-01), Christensen et al.
International J. of Obesity 1, pp. 15-42 (1977)--J. E. Blundell.
Central Mechanisms of Ansr.-Drugs, pp. 83-109 (1978)--Garattin et al. or Blundell et al.
Life Sciences 28, 77-82, (1981)--Hoebel et al.
Drugs 10(4), 241--328 (1975)-Pinder et al.
Alimentayinne Metabolism Nutrizione 1, 383 (1980), Wollesen et al.
European J. of Pharm. 32, 108-115 (1975)--Lassen et al.
Psychopharmacologia 42, 21-26 (1975)--Lassen et al.
J. Chromatogr. 133, 147-152 (1977)--Bechgaard et al.
Analytica Chimica Acta, 99, 189-192 (1978)--Bechgaard et al.
J. Neurochemistry 24,47-50 (1975)--Squires.
Lancet 1, 503-505 (1973)--Stunkard et al.
Brit. J. of Psg. 123, 501-507 (1973)--Paykel et al.
J. Pharm. Pharmac. 28, 318-320 (1976)--Goudie et al.
Arzneim-Forsch (Drug Res.) 25 (11), 1758-1762 (1975)--Duhault et al.
European J. of Pharmacol. 40, 121-130 (1976)--Sugrue et al.

Affiliated with

Also associated with

Rating

Long-term weight reduction of obese patients using femoxetine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long-term weight reduction of obese patients using femoxetine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-term weight reduction of obese patients using femoxetine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-892580